These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17848286)

  • 21. Targeted therapy in head and neck cancer: state of the art 2007 and review of clinical applications.
    Langer CJ
    Cancer; 2008 Jun; 112(12):2635-45. PubMed ID: 18442098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted therapies in squamous cell carcinoma of the head and neck.
    Gold KA; Lee HY; Kim ES
    Cancer; 2009 Mar; 115(5):922-35. PubMed ID: 19156911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging molecular targeted therapies in the treatment of head and neck cancer.
    Bozec A; Peyrade F; Fischel JL; Milano G
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):299-310. PubMed ID: 19519286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer.
    Astsaturov I; Cohen RB; Harari P
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1179-93. PubMed ID: 17020453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular-targeted therapy of head and neck squamous cell carcinoma: beyond cetuximab-based therapy.
    Machiels JP; Schmitz S
    Curr Opin Oncol; 2011 May; 23(3):241-8. PubMed ID: 21358328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired resistance to EGFR inhibitors: mechanisms and prevention strategies.
    Viloria-Petit AM; Kerbel RS
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):914-26. PubMed ID: 14967451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer.
    Mendelsohn J; Baselga J
    J Clin Oncol; 2003 Jul; 21(14):2787-99. PubMed ID: 12860957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging perspectives in epidermal growth factor receptor targeting in head and neck cancer.
    Kim S; Grandis JR; Rinaldo A; Takes RP; Ferlito A
    Head Neck; 2008 May; 30(5):667-74. PubMed ID: 18383530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidermal growth factor receptor (EGF) in head-and-neck cancers].
    Bourhis J; Tao YG; Zhang P; Deutsch E
    Bull Cancer; 2007; 94(7 Suppl):F189-91. PubMed ID: 17964995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted therapy: A novel approach in head and neck cancer.
    Christy AW; Bojan A
    Indian J Dent Res; 2013; 24(2):261-6. PubMed ID: 23965459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted therapy in head and neck cancer.
    Licitra L; Bergamini C; Mirabile A; Granata R
    Curr Opin Otolaryngol Head Neck Surg; 2011 Apr; 19(2):132-7. PubMed ID: 21372717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications.
    Zimmermann M; Zouhair A; Azria D; Ozsahin M
    Radiat Oncol; 2006 May; 1():11. PubMed ID: 16722544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zalutumumab in head and neck cancer.
    Schick U; Gujral DM; Richards TM; Harrington KJ; Nutting CM
    Expert Opin Biol Ther; 2012 Jan; 12(1):119-25. PubMed ID: 22171666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-EGFR-mediated radiosensitization as a result of augmented EGFR expression.
    Bonner JA; Buchsbaum DJ; Russo SM; Fiveash JB; Trummell HQ; Curiel DT; Raisch KP
    Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):2-10. PubMed ID: 15142629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radiotherapy and targeted therapies in head and neck carcinomas and NSCLC].
    Bruna A; Bourhis J
    Bull Cancer; 2009; 96 Suppl 1():65-8. PubMed ID: 19433375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New cytotoxic and molecular-targeted therapies of head and neck tumors.
    Caponigro F; Ionna F; Comella G
    Curr Opin Oncol; 2004 May; 16(3):225-30. PubMed ID: 15069317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cetuximab in the treatment of rheumatoid arthritis.
    Sullivan T; Benjamin CG; Kempf PW; Deeken JF
    J Clin Rheumatol; 2010 Jan; 16(1):32-3. PubMed ID: 20051754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging therapies in head and neck cancers: EGFR inhibitors.
    Held-Warmkessel J
    ONS News; 2006; 21(8 Suppl):61-2. PubMed ID: 16925156
    [No Abstract]   [Full Text] [Related]  

  • 39. Synergistic Effect of Epidermal Growth Factor Receptor Inhibitors and Ionization Radiation in Cancer Treatment.
    Shaghaghi Z; Hosseinimehr SJ
    Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):323-339. PubMed ID: 28875828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration of biomarkers including molecular targeted therapies in head and neck cancer.
    Williams MD
    Head Neck Pathol; 2010 Mar; 4(1):62-9. PubMed ID: 20237991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.